Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Lab7 Systems Launches BioBuilds, SeqSigma, and DashO3 to Accelerate and Streamline Genomic Data Processing

Published: Wednesday, September 04, 2013
Last Updated: Wednesday, September 04, 2013
Bookmark and Share
Free software and new services reduce dependencies and improve genomic workflow processes.

Lab7 Systems, Inc., announced that it has released a free software toolkit and new service offerings for the next-generation DNA sequencing (NGS) bioinformatics community, along with the latest beta version of its Lab7 Dashboard.  BioBuildsTM is a reference collection of Open Source bioinformatics tools for genomics, pre-built for Linux and Mac OS X platforms.  It eliminates the need for users to maintain and build their own versions of these tools.  By providing binaries, BioBuilds also enables users to easily reproduce results by removing version dependencies on underlying software, since all tools in BioBuilds will be pre-built for those binaries.

"Open Source software is important for bioinformatics", said Chris Mueller, Ph.D., Lab7 Systems’ President and Chief Technology Officer.  "However, building and maintaining Open Source tools can be a time consuming process.  We maintain internal builds of many analytical tools and we feel that making our builds freely available is a good way to give back to the genomics community."

BioBuilds is being released in conjunction with the second Public Beta of the Lab7 Dashboard, the company’s comprehensive software platform for managing sequencing projects, workflows, and pipelines.  This release includes the Production Pipeline Engine, a complete sequence analysis pipeline management and report generation system.  The Production Pipeline Engine allows users to easily port existing analysis pipelines into a managed, production-ready environment.  All BioBuilds tools are made readily available in the Lab7 Dashboard, even though the platform is not expressly required to run the tools.

Lab7 Systems also launched its SeqSigmaTM and DashO3TM optimization processes, integral components of the company’s larger suite of custom services.  The SeqSigma process utilizes clients’ sequencing and analysis goals to design and implement cost-effective computational infrastructures that scale with their labs, while the DashO3 pipeline optimization process identifies computational and dataflow bottlenecks in sequence analysis pipelines and can increase performance by two- to tenfold.

“Everything we’re launching today supports our vision of a streamlined environment for the management and analysis of NGS data,” concluded Dr. Mueller.  “With the tools we’re providing, we know that we can reduce the burden on bioinformaticians, scientists, and clinicians, allowing them to refocus their efforts to accelerate scientific discovery and clinical diagnoses.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!